VHCP Management as of June 30, 2012
Portfolio Holdings for VHCP Management
VHCP Management holds 17 positions in its portfolio as reported in the June 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals (IRWD) | 22.3 | $33M | 2.4M | 13.78 | |
| Neurocrine Biosciences (NBIX) | 14.3 | $21M | 2.7M | 7.89 | |
| NPS Pharmaceuticals | 10.6 | $16M | 1.8M | 8.61 | |
| Anacor Pharmaceuticals In | 8.8 | $13M | 2.0M | 6.49 | |
| Ym Biosciences | 8.0 | $12M | 6.0M | 1.99 | |
| Medivation | 7.8 | $12M | 127k | 91.40 | |
| Tesaro | 6.2 | $9.2M | 657k | 13.99 | |
| GTx | 5.1 | $7.5M | 2.1M | 3.52 | |
| ACADIA Pharmaceuticals (ACAD) | 4.0 | $5.9M | 3.4M | 1.76 | |
| Spectrum Pharmaceuticals | 3.7 | $5.4M | 350k | 15.56 | |
| Chelsea Therapeutics International | 3.5 | $5.1M | 3.4M | 1.48 | |
| Biodel | 2.2 | $3.3M | 1.3M | 2.58 | |
| Alexza Pharmaceuticals | 1.4 | $2.1M | 500k | 4.24 | |
| Orexigen Therapeutics | 0.9 | $1.3M | 235k | 5.54 | |
| Array BioPharma | 0.8 | $1.2M | 354k | 3.47 | |
| Anthera Pharmaceuticals | 0.3 | $434k | 638k | 0.68 | |
| XenoPort | 0.1 | $167k | 28k | 6.03 |
